Jae-Hyun Seo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jae-Hyun Seo has a total of 188 co-authors. Here are the top co-authors by number of shared publications:
- Jae Sang Han
Department of Otolaryngology-Head and Neck Surgery, Eunpyeong St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
20 shared publications - Shi Nae Park
Department of Otolaryngology-Head and Neck Surgery, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
19 shared publications - Ji Hyung Lim
Department of Otolaryngology-Head and Neck Surgery, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
9 shared publications - Moo Kyun Park
Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea
8 shared publications - Jae-Jun Song
Department of Otorhinolaryngology-Head and Neck Surgery Korea University Guro Hospital Korea University College of Medicine Seoul Korea
7 shared publications - So Young Park
Department of Otolaryngology‐Head and Neck Surgery Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea Seoul Korea
6 shared publications
Latest Publications
- Open Access
- 15 March 2026
- Published by The Korean Balance Society in Research in Vestibular Science
- Vol. 25 (1) , 45-53
Diagnostic validity of monothermal caloric screening test: a large-scale comparative study with bithermal standards
Objectives: This study aimed to assess the diagnostic performance of the monothermal caloric screening test (MCST) compared with the bithermal caloric test (BCT) for detecting vestibular asymmetry and to compare diagnostic performance between warm and cool stimulation as well as between air and water irrigation.Methods: This retrospective study analyzed 971 consecutive patients who underwent caloric testing (470 air, 501 water). Diagnostic performance of warm MCST and cool MCST was evaluated using BCT canal paresis (CP) thresholds of ≥20% and ≥25% as reference standards. Correlation and directional agreement were assessed using Pearson correlation and Cohen’s κ.Results: Warm MCST demonstrated superior diagnostic performance with a sensitivity of 97.4%, specificity of 58.5%, negative predictive value (NPV) of 98.3%, and the area under the curve (AUC) of 0.948 at a CP ≥25% threshold. Cool MCST showed comparable sensitivity (96.0%) but lower specificity (37.6%) and AUC (0.915). Bithermal CP correlated very strongly with warm monothermal caloric asymmetry (MCA) (r=0.95) versus moderately with cool MCA (r=0.90), with substantial directional agreement for warm (κ=0.65) but only moderate for cool (κ=0.49). Warm stimulation elicited significantly greater responses than cool (26.97%±27.2% vs. 22.82%±25.5%, p0.2), whereas water was superior for cool testing (p=0.029).Conclusions: Monothermal warm caloric testing provides excellent screening accuracy (sensitivity and NPV >95%) with strong concordance to bithermal testing. Warm MCST can be recommended as a first-line screening tool, with complete bithermal testing reserved for positive cases requiring detailed quantification.
- 15 March 2026
- Published by The Korean Balance Society in Research in Vestibular Science
- Vol. 25 (1) , 45-53
Open AccessDiagnostic validity of monothermal caloric screening test: a large-scale comparative study with bithermal standards
Objectives: This study aimed to assess the diagnostic performance of the monothermal caloric screening test (MCST) compared with the bithermal caloric test (BCT) for detecting vestibular asymmetry and to compare diagnostic performance between warm and cool stimulation as well as between air and water irrigation.Methods: This retrospective study analyzed 971 consecutive patients who underwent caloric testing (470 air, 501 water). Diagnostic performance of warm MCST and cool MCST was evaluated using BCT canal paresis (CP) thresholds of ≥20% and ≥25% as reference standards. Correlation and directional agreement were assessed using Pearson correlation and Cohen’s κ.Results: Warm MCST demonstrated superior diagnostic performance with a sensitivity of 97.4%, specificity of 58.5%, negative predictive value (NPV) of 98.3%, and the area under the curve (AUC) of 0.948 at a CP ≥25% threshold. Cool MCST showed comparable sensitivity (96.0%) but lower specificity (37.6%) and AUC (0.915). Bithermal CP correlated very strongly with warm monothermal caloric asymmetry (MCA) (r=0.95) versus moderately with cool MCA (r=0.90), with substantial directional agreement for warm (κ=0.65) but only moderate for cool (κ=0.49). Warm stimulation elicited significantly greater responses than cool (26.97%±27.2% vs. 22.82%±25.5%, p0.2), whereas water was superior for cool testing (p=0.029).Conclusions: Monothermal warm caloric testing provides excellent screening accuracy (sensitivity and NPV >95%) with strong concordance to bithermal testing. Warm MCST can be recommended as a first-line screening tool, with complete bithermal testing reserved for positive cases requiring detailed quantification.
- Open Access
- 1 January 2026
- Published by XMLink in Journal of Korean Medical Science
- Vol. 41 (15) , e131
Comparison of the Hearing Benefits and User Satisfaction With Hearing Aids and Personal Sound Amplification Products: A Multicenter Prospective Randomized Crossover Trial
Han JS, et al. J Korean Med Sci. 2026 Apr;41:e131. https://doi.org/10.3346/jkms.2026.41.e131
- 1 January 2026
- Published by XMLink in Journal of Korean Medical Science
- Vol. 41 (15) , e131
Open AccessComparison of the Hearing Benefits and User Satisfaction With Hearing Aids and Personal Sound Amplification Products: A Multicenter Prospective Randomized Crossover Trial
Han JS, et al. J Korean Med Sci. 2026 Apr;41:e131. https://doi.org/10.3346/jkms.2026.41.e131
- Open Access
- 1 January 2026
- Published by XMLink in Journal of Korean Medical Science
- Vol. 41 (12) , e99
The Impact of Vitamin D Deficiency and Osteoporosis on Benign Paroxysmal Positional Vertigo Recurrence: A Population-Based Study From the Korean National Health Insurance Service
Kwak SH, et al. J Korean Med Sci. 2026 Mar;41(12):e99. https://doi.org/10.3346/jkms.2026.41.e99
- 1 January 2026
- Published by XMLink in Journal of Korean Medical Science
- Vol. 41 (12) , e99
Open AccessThe Impact of Vitamin D Deficiency and Osteoporosis on Benign Paroxysmal Positional Vertigo Recurrence: A Population-Based Study From the Korean National Health Insurance Service
Kwak SH, et al. J Korean Med Sci. 2026 Mar;41(12):e99. https://doi.org/10.3346/jkms.2026.41.e99
- Open Access
- 1 January 2026
- Published by XMLink in Journal of Korean Medical Science
- Vol. 41 (7) , e71
Clinical Impact of Candida auris in Otology: Prevalence and Surgical Outcomes From a Single-Center Study in Korea
Han JS, et al. J Korean Med Sci. 2026 Feb;41(7):e71. https://doi.org/10.3346/jkms.2026.41.e71
- 1 January 2026
- Published by XMLink in Journal of Korean Medical Science
- Vol. 41 (7) , e71
Open AccessClinical Impact of Candida auris in Otology: Prevalence and Surgical Outcomes From a Single-Center Study in Korea
Han JS, et al. J Korean Med Sci. 2026 Feb;41(7):e71. https://doi.org/10.3346/jkms.2026.41.e71
- Open Access
- 20 October 2025
- Published by The Korean Audiological Society in Journal of Audiology and Otology
- Vol. 29 (4) , 237-241
Practical Guidelines for Smartphone-Based Hearing Aid Application and Personal Sound Amplification Device Usage to Correct Hearing Loss in Korea Based on a Randomized Controlled Trial by the Patient-Centered Clinical Research Coordinating Center
The prevalence of mild-to-moderate hearing loss is increasing due to noise exposure and an expanding elderly population. Despite the benefits of hearing aids, many individuals avoid them due to cost and incomplete awareness, opting instead for smartphone-based hearing aid applications (SHAAs) and personal sound amplification products (PSAPs). However, these devices are currently lacking official approval for medical use. The study results, together with roundtable discussions organized by the Patient-Centered Clinical Research Coordinating Center (PACEN) and recent research findings, were reviewed to develop clinical guidelines. The roundtable discussions involved seven otology experts and one lay representative and focused on defining PSAPs and establishing minimum requirements for their use by patients with hearing loss. Hearing aids were found to effectively address all types of hearing loss and improve speech recognition in noisy environments. In contrast, SHAA and PSAP are effective only under specific conditions: SHAA for mild loss and PSAP for mild-to-moderate loss. Both devices perform poorly in noisy settings and lack noise processing features. Hearing aids are recommended as the most effective and versatile option for auditory rehabilitation, whereas SHAA and PSAP should only be considered under defined conditions when hearing aids are impractical. Continued updates and cost-effectiveness evaluations will be required as technologies advance.
- 20 October 2025
- Published by The Korean Audiological Society in Journal of Audiology and Otology
- Vol. 29 (4) , 237-241
Open AccessPractical Guidelines for Smartphone-Based Hearing Aid Application and Personal Sound Amplification Device Usage to Correct Hearing Loss in Korea Based on a Randomized Controlled Trial by the Patient-Centered Clinical Research Coordinating Center
The prevalence of mild-to-moderate hearing loss is increasing due to noise exposure and an expanding elderly population. Despite the benefits of hearing aids, many individuals avoid them due to cost and incomplete awareness, opting instead for smartphone-based hearing aid applications (SHAAs) and personal sound amplification products (PSAPs). However, these devices are currently lacking official approval for medical use. The study results, together with roundtable discussions organized by the Patient-Centered Clinical Research Coordinating Center (PACEN) and recent research findings, were reviewed to develop clinical guidelines. The roundtable discussions involved seven otology experts and one lay representative and focused on defining PSAPs and establishing minimum requirements for their use by patients with hearing loss. Hearing aids were found to effectively address all types of hearing loss and improve speech recognition in noisy environments. In contrast, SHAA and PSAP are effective only under specific conditions: SHAA for mild loss and PSAP for mild-to-moderate loss. Both devices perform poorly in noisy settings and lack noise processing features. Hearing aids are recommended as the most effective and versatile option for auditory rehabilitation, whereas SHAA and PSAP should only be considered under defined conditions when hearing aids are impractical. Continued updates and cost-effectiveness evaluations will be required as technologies advance.
- 30 September 2025
- Published by Wiley in The Laryngoscope
- Vol. 136 (2) , 927-931
Managing Venous Pulsatile Tinnitus Using Intraoperative Doppler Ultrasound: How I Do It
Intraoperative Doppler ultrasound (IDU) can determine the exact location of sigmoid sinus dehiscence (SS-deh), diverticulum (SS-div) and large emissary vein (LEV). Furthermore, real-time measurement of the sufficiency during surgical SS-deh resurfacing procedures, periosteal flap insertion into the SS-div or LEV compression is possible with IDU.
- 30 September 2025
- Published by Wiley in The Laryngoscope
- Vol. 136 (2) , 927-931
Managing Venous Pulsatile Tinnitus Using Intraoperative Doppler Ultrasound: How I Do It
Intraoperative Doppler ultrasound (IDU) can determine the exact location of sigmoid sinus dehiscence (SS-deh), diverticulum (SS-div) and large emissary vein (LEV). Furthermore, real-time measurement of the sufficiency during surgical SS-deh resurfacing procedures, periosteal flap insertion into the SS-div or LEV compression is possible with IDU.
- Open Access
- 25 July 2025
- Published by Wiley in The Laryngoscope
- Vol. 136 (1) , 403-410
Efficacy and Safety of Intratympanic Botulinum Toxin Injection on Middle Ear Myoclonic Tinnitus
Objectives: Investigating the efficacy and safety of intratympanic Botulinum toxin (IT‐BTX) injection as a novel treatment for middle ear myoclonic tinnitus (MEMT). Methods: Medical records and tinnitus questionnaires of the patients with MEMT who underwent IT‐BTX were retrospectively reviewed. The efficacy of IT‐BTX on MEMT as well as its safety were evaluated by audiology tests and tinnitus questionnaires. Results: A total of 57 patients who completed the questionnaires at pre‐ and post‐IT‐BTX were enrolled. Tinnitus handicap inventory (THI) scores decreased significantly from pre‐IT‐BTX (44.31 ± 26.8) to 31.42 ± 23.6 ( p < 0.001), 32.92 ± 24.9 ( p = 0.004), and 25.71 ± 22.9 ( p < 0.001) at 1‐, 3‐, and 6‐months post‐IT‐BTX, respectively. Additionally, visual analog scales (VAS) of loudness (LD), awareness (AW), annoyance (AN), and effect on life (EF) significantly decreased post‐IT‐BTX ( p < 0.05): LD from 4.19 ± 2.4 to 2.47 ± 2.0, 2.89 ± 2.2, and 2.38 ± 1.9 at 1‐, 3‐, and 6‐months; AW from 41.75 ± 29.5 to 24.38 ± 23.3, 26.94 ± 23.3, and 22.10 ± 21.7; AN from 5.00 ± 2.8 to 2.82 ± 2.1, 3.47 ± 2.4, and 2.78 ± 2.2; EF from 4.82 ± 2.8 to 2.89 ± 2.2, 3.28 ± 2.4, and 2.73 ± 2.2 at 1‐, 3‐, and 6‐months post‐IT‐BTX. Notably, 40.3% of the IT‐BTX patients experienced a complete cure of their MEMT symptoms, while 50.8% demonstrated partial resolution after IT‐BTX. There were no side effects or complications after IT‐BTX during their follow‐up period. Comparing delta values between the single injection group and multiple injection group revealed significant differences in VAS LD at the post‐1‐month time point and between the 1‐month and 6‐month intervals. Conclusion: IT‐BTX is an effective, safe treatment for MEMT, significantly improving symptoms without complications, and offers a promising alternative before middle ear tendon resection. Level of Evidence: 4:
- 25 July 2025
- Published by Wiley in The Laryngoscope
- Vol. 136 (1) , 403-410
Open AccessEfficacy and Safety of Intratympanic Botulinum Toxin Injection on Middle Ear Myoclonic Tinnitus
Objectives: Investigating the efficacy and safety of intratympanic Botulinum toxin (IT‐BTX) injection as a novel treatment for middle ear myoclonic tinnitus (MEMT). Methods: Medical records and tinnitus questionnaires of the patients with MEMT who underwent IT‐BTX were retrospectively reviewed. The efficacy of IT‐BTX on MEMT as well as its safety were evaluated by audiology tests and tinnitus questionnaires. Results: A total of 57 patients who completed the questionnaires at pre‐ and post‐IT‐BTX were enrolled. Tinnitus handicap inventory (THI) scores decreased significantly from pre‐IT‐BTX (44.31 ± 26.8) to 31.42 ± 23.6 ( p < 0.001), 32.92 ± 24.9 ( p = 0.004), and 25.71 ± 22.9 ( p < 0.001) at 1‐, 3‐, and 6‐months post‐IT‐BTX, respectively. Additionally, visual analog scales (VAS) of loudness (LD), awareness (AW), annoyance (AN), and effect on life (EF) significantly decreased post‐IT‐BTX ( p < 0.05): LD from 4.19 ± 2.4 to 2.47 ± 2.0, 2.89 ± 2.2, and 2.38 ± 1.9 at 1‐, 3‐, and 6‐months; AW from 41.75 ± 29.5 to 24.38 ± 23.3, 26.94 ± 23.3, and 22.10 ± 21.7; AN from 5.00 ± 2.8 to 2.82 ± 2.1, 3.47 ± 2.4, and 2.78 ± 2.2; EF from 4.82 ± 2.8 to 2.89 ± 2.2, 3.28 ± 2.4, and 2.73 ± 2.2 at 1‐, 3‐, and 6‐months post‐IT‐BTX. Notably, 40.3% of the IT‐BTX patients experienced a complete cure of their MEMT symptoms, while 50.8% demonstrated partial resolution after IT‐BTX. There were no side effects or complications after IT‐BTX during their follow‐up period. Comparing delta values between the single injection group and multiple injection group revealed significant differences in VAS LD at the post‐1‐month time point and between the 1‐month and 6‐month intervals. Conclusion: IT‐BTX is an effective, safe treatment for MEMT, significantly improving symptoms without complications, and offers a promising alternative before middle ear tendon resection. Level of Evidence: 4:
- Open Access
- 31 May 2025
- Published by Korean Society of Otorhinolaryngology-Head and Neck Surgery in Clinical and Experimental Otorhinolaryngology
- Vol. 18 (2) , 123-133
Risk Factors Associated With the Occurrence and Recurrence of Benign Paroxysmal Positional Vertigo in Koreans: A Nested Case-Control Study
Objectives. Benign paroxysmal positional vertigo (BPPV) is the most prevalent cause of vertigo. This study aims to analyze the risk factors associated with the occurrence and recurrence of BPPV.Methods. A database maintained by the Korean National Health Insurance Service was used to analyze 434,552 patients diagnosed with BPPV from 2011 to 2017. The propensity score matching technique was employed to pair each participant with a control patient who did not have BPPV, ensuring equivalence in age, sex, residential status, and socioeconomic status. BPPV recurrence was defined as a new episode occurring more than 90 days after the initial treatment. Logistic regression analysis was conducted to examine the incidence of BPPV, while Cox proportional hazards models were used to investigate the risk factors associated with its recurrence.Results. BPPV was found to be 2.2 times more prevalent in women, particularly peaking between the ages of 50 and 59. The 5-year recurrence rate for BPPV stood at 39.8%, with a significant number of cases reoccurring within the first year. The incidence of BPPV was statistically significantly linked to several underlying medical conditions, including vitamin D deficiency, thyroid hormone abnormalities, head trauma, and inner ear disorders. Notable risk factors for BPPV recurrence included advanced age, female sex, rural residence, low socioeconomic status, and the presence of inner ear diseases.Conclusion. Our study provides significant insights into the risk factors linked to both the occurrence and recurrence of BPPV. Notably, there appears to be a connection with vitamin D levels, thyroid hormones, and estrogen. Additionally, conditions such as inner-ear disorders, head trauma, and otologic surgery were found to be strongly associated with both the initial onset and subsequent recurrence of BPPV.
- 31 May 2025
- Published by Korean Society of Otorhinolaryngology-Head and Neck Surgery in Clinical and Experimental Otorhinolaryngology
- Vol. 18 (2) , 123-133
Open AccessRisk Factors Associated With the Occurrence and Recurrence of Benign Paroxysmal Positional Vertigo in Koreans: A Nested Case-Control Study
Objectives. Benign paroxysmal positional vertigo (BPPV) is the most prevalent cause of vertigo. This study aims to analyze the risk factors associated with the occurrence and recurrence of BPPV.Methods. A database maintained by the Korean National Health Insurance Service was used to analyze 434,552 patients diagnosed with BPPV from 2011 to 2017. The propensity score matching technique was employed to pair each participant with a control patient who did not have BPPV, ensuring equivalence in age, sex, residential status, and socioeconomic status. BPPV recurrence was defined as a new episode occurring more than 90 days after the initial treatment. Logistic regression analysis was conducted to examine the incidence of BPPV, while Cox proportional hazards models were used to investigate the risk factors associated with its recurrence.Results. BPPV was found to be 2.2 times more prevalent in women, particularly peaking between the ages of 50 and 59. The 5-year recurrence rate for BPPV stood at 39.8%, with a significant number of cases reoccurring within the first year. The incidence of BPPV was statistically significantly linked to several underlying medical conditions, including vitamin D deficiency, thyroid hormone abnormalities, head trauma, and inner ear disorders. Notable risk factors for BPPV recurrence included advanced age, female sex, rural residence, low socioeconomic status, and the presence of inner ear diseases.Conclusion. Our study provides significant insights into the risk factors linked to both the occurrence and recurrence of BPPV. Notably, there appears to be a connection with vitamin D levels, thyroid hormones, and estrogen. Additionally, conditions such as inner-ear disorders, head trauma, and otologic surgery were found to be strongly associated with both the initial onset and subsequent recurrence of BPPV.
- Open Access
- 1 January 2025
- Published by XMLink in Journal of Korean Medical Science
- Vol. 40 (7) , e93
Consensus Statements on Tinnitus Assessment and Treatment Outcome Evaluation: A Delphi Study by the Korean Tinnitus Study Group
Choo OS, et al. J Korean Med Sci. 2025 Feb;40:e93. https://doi.org/10.3346/jkms.2025.40.e93
- 1 January 2025
- Published by XMLink in Journal of Korean Medical Science
- Vol. 40 (7) , e93
Open AccessConsensus Statements on Tinnitus Assessment and Treatment Outcome Evaluation: A Delphi Study by the Korean Tinnitus Study Group
Choo OS, et al. J Korean Med Sci. 2025 Feb;40:e93. https://doi.org/10.3346/jkms.2025.40.e93
- Open Access
- 1 January 2025
- Published by XMLink in Journal of Korean Medical Science
- Vol. 40 (18) , e75
Consensus Statements on Tinnitus Treatment: A Delphi Study by the Korean Tinnitus Study Group
Jeong J, et al. J Korean Med Sci. 2025 Jan;40:e75. https://doi.org/10.3346/jkms.2025.40.e75
- 1 January 2025
- Published by XMLink in Journal of Korean Medical Science
- Vol. 40 (18) , e75
Open AccessConsensus Statements on Tinnitus Treatment: A Delphi Study by the Korean Tinnitus Study Group
Jeong J, et al. J Korean Med Sci. 2025 Jan;40:e75. https://doi.org/10.3346/jkms.2025.40.e75